目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Drug Class
1.1.2. Product
1.1.3. Route of Administration
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Drug class outlook
2.2.2. Product outlook
2.2.3. Route of administration outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Asthma Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing incidence of asthma
3.3.1.2. Introduction of novel biologics
3.3.1.3. Rising government initiatives
3.3.2. Market restraint analysis
3.4. Asthma Therapeutics Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape

Chapter 4. Asthma Therapeutics Market: Drug Class Estimates & Trend Analysis
4.1. Asthma Therapeutics Market: Key Takeaways
4.2. Asthma Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Anti-inflammatory
4.3.1. Anti-inflammatory market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Bronchodilators
4.4.1. Bronchodilators market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Combination Therapy
4.5.1. Combination therapy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Asthma Therapeutics Market: Product Estimates & Trend Analysis
5.1. Asthma Therapeutics Market: Key Takeaways
5.2. Asthma Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Inhalers
5.3.1. Inhalers market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.2. Dry powder inhalers
5.3.2.1. Dry powder inhalers market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.3. Metered-dose inhalers
5.3.3.1. Metered-dose inhalers market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.4. Soft mist inhalers
5.3.4.1. Soft mist inhalers market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Nebulizers
5.4.1. Nebulizers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Asthma Therapeutics Market: Route of Administration Estimates & Trend Analysis
6.1. Asthma Therapeutics Market: Key Takeaways
6.2. Asthma Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Oral
6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Inhaled
6.4.1. Inhaled market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Others
6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Asthma Therapeutics Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Asthma Therapeutics Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Teva Pharmaceutical Industries Ltd.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. GSK plc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Merck& Co., Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. F. Hoffmann-La Roche Ltd
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. AstraZeneca
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Boehringer Ingelheim International GmbH.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Sanofi
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Koninklijke Philips N.V.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. BD
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Sunovion Pharmaceuticals, Inc.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviations
Table 2 North America asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 3 North America asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 4 North America asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 5 North America asthma therapeutics market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 7 U.S. asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 9 Canada asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 10 Canada asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 11 Canada asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 12 Europe asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 13 Europe asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 14 Europe asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 15 Europe asthma therapeutics market, by region, 2018 - 2030 (USD Million)
Table 16 Germany asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 17 Germany asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 18 Germany asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 19 UK asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 20 UK asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 21 UK asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 22 France asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 23 France asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 24 France asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 25 Italy asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 26 Italy asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 27 Italy asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 28 Spain asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 29 Spain asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 30 Spain asthma therapeutics market, by route of administration, (USD Million) 2018 - 2030
Table 31 Denmark asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 32 Denmark asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 33 Denmark asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 34 Sweden asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 35 Sweden asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 36 Sweden asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 37 Norway asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 38 Norway asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 39 Norway asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 40 Asia Pacific asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 41 Asia Pacific asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 43 Asia Pacific asthma therapeutics market, by region, 2018 - 2030 (USD Million)
Table 44 Japan asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 45 Japan asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 46 Japan asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 47 China asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 48 China asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 49 China asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 50 India asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 51 India asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 52 India asthma therapeutics market, by route of administration, (USD Million) 2018 - 2030
Table 53 Australia asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 54 Australia asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 55 Australia asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 56 Thailand asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 57 Thailand asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 58 Thailand asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 59 South Korea asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 60 South Korea asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 61 South Korea asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 62 Latin America asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 63 Latin America asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 64 Latin America asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 65 Latin America asthma therapeutics market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 67 Brazil asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 68 Brazil asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 69 Mexico asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 70 Mexico asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 71 Mexico asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 72 Argentina asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 73 Argentina asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 74 Argentina asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa asthma therapeutics market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 80 South Africa asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 81 South Africa asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 85 UAE asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 86 UAE asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 87 UAE asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 88 Kuwait asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 89 Kuwait asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 90 Kuwait asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Asthma therapeutics: Market outlook
Fig. 9 Asthma therapeutics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Asthma therapeutics market driver impact
Fig. 15 Asthma therapeutics market restraint impact
Fig. 16 Asthma therapeutics market strategic initiatives analysis
Fig. 17 Asthma therapeutics market: Drug class movement analysis
Fig. 18 Asthma therapeutics market: Drug class outlook and key takeaways
Fig. 19 Anti-inflammatory market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Bronchodilators market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Combination therapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Asthma therapeutics market: Product movement analysis
Fig. 23 Asthma therapeutics market: Product outlook and key takeaways
Fig. 24 Inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Dry powder inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Metered-dose inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Soft mist inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Asthma therapeutics market: Route of administration movement analysis
Fig. 30 Asthma therapeutics market: Route of administration outlook and key takeaways
Fig. 31 Oral market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Inhaled market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Global asthma therapeutics market: Regional movement analysis
Fig. 35 Global asthma therapeutics market: Regional outlook and key takeaways
Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)